Philadelphia Inquirer -- David R. King, a lawyer-turned-chief executive officer who ran and sold three Philadelphia-area biotech firms, is moving to the other side of the transaction ledger. King is joining $700-million-asset investment firm Quaker BioVentures Inc., of West Philadelphia, as a venture partner focusing on merger-and-acquisition deals.
